ASTS
ASTS
Above both MAs and best 1-month relative strength in space cohort
Price
Price at analysis
$89.57
The case
● Bull — what supports it
FCC commercial SCS authorization, BlueBird 8/9/10 launch mid-June (near catalyst), ~60 MNO partners / 3B subs, +8.5% on month.
● Bear — what refutes it
ADX 28 down with RSI 38, 13% ATR; binary launch risk and SpaceX IPO sector pressure.
What would change our mind
Drake commits in advance to what would prove this call wrong — falsifiers, not hindsight.
- Failed/scrubbed BlueBird launch or loss of 50DMA would break the setup.
The verdict
Sector analyst (Drake panel)–neutral
conviction 0.55
- Above both MAs and best 1-month relative strength in space cohort
- But imminent launch is binary — hold, don't add ahead of it
Risks: ADX 28 down with RSI 38, 13% ATR; binary launch risk and SpaceX IPO sector pressure.
Forward-only: this call is graded against the future, on its resolution date — never backfilled. This run carries a single synthesized panel verdict; multi-specialist runs list each view above.